RSNA 2014 

Abstract Archives of the RSNA, 2014


GUS101

Pseudonormal Corticomedullary Differentiation of the Kidney Assessed by T1-weighted MRI in Cirrhotic Patients with Chronic Kidney Disease

Scientific Posters

Presented on November 30, 2014
Presented as part of GUS-SUA: Genitourinary/Uroradiology Sunday Poster Discussions

Participants

Fumi Yamada MD, Presenter: Nothing to Disclose
Yasuo Amano MD, Abstract Co-Author: Nothing to Disclose
Fumitaka Hidaka MD, Abstract Co-Author: Nothing to Disclose
Yoshimitsu Fukushima, Abstract Co-Author: Nothing to Disclose
Shinichiro Kumita MD, Abstract Co-Author: Nothing to Disclose

PURPOSE

Corticomedullary differentiation (CMD) of the kidney on T1-weighted magnetic resonance imaging(MRI) increases in cirrhotic patients with normal renal function, compared with normal controls. If the pathological conditon also occurs in cirrhotic patients with chronic kidney disease (CKD), the severity of renal insufficiency can be underestimated by T1-weighted MRI. The aim of this study was to determine whether CMD in cirrhotic patients with CKD increased to a "pseudonormal" appearance on the T1-weighted images.

METHOD AND MATERIALS

Abdominal T1-weighted MRI was performed in 32 cirrhotic patients with CKD and 32 age-matched CKD patients without liver cirrhosis. Estimated glomerular filtration rate  (eGFR) did not differ between them (P= 0.43). Visual CMD was assessed using a 3-point scale (i.e. good, moderate, poor). Quantitative CMD was calculated by (signal intensity of the cortex / signal intensity of the medulla) for patients with visually good and moderate CMD. Differences in the proportions of the visual CMD scores were assessed between the patients with and without liver cirrhosis. We evaluated the differences in eGFR between the good, moderate, and poor scores of the patients with or without liver cirrhosis. We also assessed correlations between the quantitative CMD and eGFR in the patients with and without cirrhosis.

RESULTS

For visual CMD, the proportions of patients in each of the three scores were different between patients with and without liver cirrhosis: more good and fewer poor CMD in the cirrhotic patients (P= 0.048). In cirrhotic patients, eGFR differed between poor CMD and good or moderate CMD (P< 0.01), but not between good and moderate CMD. There were significant differences in eGFR between the three visual scores in CKD patients without cirrhosis (P< 0.05). No significant correlation was observed between quantitative CMD and eGFR in the cirrhotic patients (P= 0.22), in contrast to the CKD patients without cirrhosis (P< 0.05, r= 0.62).

CONCLUSION

Cirrhotic patients with CKD had pseudonormal CMD of the kidney on the T1-weighted MRI. We should interpret CMD carefully in the patients with both liver cirrhosis and CKD.

CLINICAL RELEVANCE/APPLICATION

T1-weighted MRI is useful for identifying chronic kidney diseases in daily practice, but not necessarily in cirrhotic patients because of pseudonormal corticomedullary differentiation of the kidney.

Cite This Abstract

Yamada, F, Amano, Y, Hidaka, F, Fukushima, Y, Kumita, S, Pseudonormal Corticomedullary Differentiation of the Kidney Assessed by T1-weighted MRI in Cirrhotic Patients with Chronic Kidney Disease.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14005073.html